Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Amylyx Pharmaceuticals, Inc. (AMLX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
23 Feb 2024
Mazzariello Gina
Chief Legal Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
46,245
-5%
2,838
$18.76
$53,230.66
SELL
9 Jan 2024
Yeramian Patrick D
Chief Medical Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
205,605
-1%
2,812
$16.33
$45,914.62
SELL
9 Jan 2024
Klee Justin B.
Co-Chief Executive Officer, Director, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
2,836,776
-0%
5,841
$16.33
$95,372.43
SELL
9 Jan 2024
FRATES JAMES M
Chief Financial Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
112,035
-2%
2,716
$16.33
$44,347.12
SELL
9 Jan 2024
Cohen Joshua B
Co-Chief Executive Officer, Director, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
2,900,470
-0%
5,841
$16.33
$95,372.43
BUY
15 Dec 2023
Firestone Karen
Director
Amylyx Pharmaceuticals, Inc.
(AMLX)
5,000
+400%
4,000
$14.97
$59,880.00
SELL
15 Aug 2023
Mazzariello Gina
Chief Legal Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
49,083
-11%
6,164
$20.88
$128,686.45
SELL
16 May 2023
FRATES JAMES M
Chief Financial Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
56,176
-36%
32,500
$26.94
$875,451.20
SELL
15 May 2023
Yeramian Patrick D
Chief Medical Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
208,417
-5%
11,965
$29.03
$347,358.30
SELL
17 Apr 2023
Yeramian Patrick D
Chief Medical Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
208,717
-19%
49,579
$30.54
$1,513,942.40
SELL
29 Mar 2023
Morningside Venture Investments Ltd
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
6,997,302
-0%
29,048
$30.45
$884,511.60
SELL
27 Mar 2023
Morningside Venture Investments Ltd
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
7,026,350
-2%
160,964
$30.42
$4,896,561.00
SELL
21 Mar 2023
Morningside Venture Investments Ltd
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
7,216,121
-0%
63,448
$31.91
$2,024,494.40
SELL
16 Mar 2023
Morningside Venture Investments Ltd
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
7,250,762
-0%
9,122
$32.55
$296,921.10
SELL
16 Mar 2023
FRATES JAMES M
Chief Financial Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
3,213
-91%
32,500
$31.89
$1,036,459.20
BUY
16 Mar 2023
Firestone Karen
Director
Amylyx Pharmaceuticals, Inc.
(AMLX)
1,000
+100%
1,000
$31.99
$31,990.00
SELL
16 Mar 2023
Cohen Joshua B
Co-Chief Executive Officer, Director, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
2,796,541
-3%
100,000
$31.86
$3,186,335.80
SELL
16 Mar 2023
MILNE GEORGE M JR
Director
Amylyx Pharmaceuticals, Inc.
(AMLX)
863,937
-3%
35,000
$31.89
$1,116,072.50
SELL
16 Mar 2023
Yeramian Patrick D
Chief Medical Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
152,088
-26%
54,627
$31.87
$1,741,200.40
SELL
16 Mar 2023
Klee Justin B.
Co-Chief Executive Officer, Director, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
2,796,062
-3%
100,000
$31.86
$3,186,236.20
SELL
16 Mar 2023
Yeramian Patrick D
Chief Medical Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
201,666
-21%
54,627
$31.87
$1,741,200.40
SELL
16 Mar 2023
FRATES JAMES M
Chief Financial Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
35,713
-47%
32,500
$31.89
$1,036,459.20
SELL
14 Mar 2023
Morningside Venture Investments Ltd
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
7,300,950
-2%
220,714
$33.68
$7,433,458.50
SELL
2 Mar 2023
Morningside Venture Investments Ltd
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
7,480,598
-0%
50,000
$33.75
$1,687,500.00
SELL
24 Feb 2023
Morningside Venture Investments Ltd
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
7,532,710
-0%
50,000
$34.73
$1,736,351.80
SELL
24 Feb 2023
Mazzariello Gina
Chief Legal Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
37,414
-8%
3,586
$34.49
$123,671.82
SELL
22 Feb 2023
Morningside Venture Investments Ltd
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
7,581,709
-1%
100,000
$35.78
$3,578,102.80
BUY
6 Jan 2023
Klee Justin B.
Co-Chief Executive Officer, Director, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
2,894,463
+0%
5,968
$36.30
$216,629.34
BUY
6 Jan 2023
Olinger Margaret
Chief Commercial Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
215,098
+1%
2,403
$36.30
$87,225.05
BUY
6 Jan 2023
Cohen Joshua B
Co-Chief Executive Officer, Director, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
2,894,463
+0%
5,968
$36.30
$216,629.34
BUY
6 Jan 2023
FRATES JAMES M
Chief Financial Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
34,831
+8%
2,658
$36.30
$96,481.25
BUY
6 Jan 2023
Yeramian Patrick D
Chief Medical Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
204,928
+1%
2,034
$36.30
$73,831.01
BUY
12 Oct 2022
Christopher L. Jacobs
Congressman (House)
Amylyx Pharmaceuticals, Inc.
(AMLX)
N/A
N/A
N/A
$1,001 - $15,000
SELL
8 Sep 2022
VIKING GLOBAL INVESTORS LP
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
4,082,713
-25%
1,400,000
$29.80
$41,719,636.00
SELL
6 Jul 2022
ALS Invest 1 B.V.
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
5,937,577
-1%
60,609
$20.70
$1,254,641.90
BUY
11 Jan 2022
VIKING GLOBAL INVESTORS LP
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
2,300,000
+100%
2,300,000
$19.00
$43,700,000.00
BUY
6 Jan 2022
Cheng Isaac
Director
Amylyx Pharmaceuticals, Inc.
(AMLX)
6,578
+100%
6,578
$19.00
$124,982.00
BUY
6 Jan 2022
MILNE GEORGE M JR
Director
Amylyx Pharmaceuticals, Inc.
(AMLX)
221,396
+13%
26,315
$19.00
$499,985.00
BUY
6 Jan 2022
Morningside Venture Investments Ltd
10% Owner
Amylyx Pharmaceuticals, Inc.
(AMLX)
10,678,808
+2%
263,158
$19.00
$5,000,002.00
BUY
6 Jan 2022
Olinger Margaret
Chief Commercial Officer, Officer
Amylyx Pharmaceuticals, Inc.
(AMLX)
216,758
+3%
6,842
$19.00
$129,998.00
BUY
6 Jan 2022
FONTEYNE PAUL R.
Director
Amylyx Pharmaceuticals, Inc.
(AMLX)
3,947
+100%
3,947
$19.00
$74,993.00
Home